SCT-SFNano Joint Meeting

When Medicinal Chemistry meets Nanomedicines: Molecular Aspects of Targeting, Activation and Delivery of Drugs

 Paris, France    April 8, 2014

Programme


Session Chair

Dr Pascal GEORGE
SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France

09:30

Introduction

09:45

Mechanism Based Delivery Systems (Tentative title)

Dr John F. GILMER
TRINITY COLLEGE DUBLIN, dublin, Ireland

10:30

Coffee Break

Session Chair

Prof. Bernard LEBLEU
INDEPENDENT SCIENTIFIC EXPERT, SFNANO, Montpellier, France

11:00

On the Cutting Edge: Proteolytically-Induced Drug Delivery in Imaging and Photodynamic Therapy

Prof. Norbert LANGE
UNIVERSITY OF GENEVA, Geneva, Switzerland

Session Chair

Dr Frédéric SCHMIDT
INSTITUT CURIE, Paris, France

11:45

Designing Polymer-Based Combination Therapy for the Treatment of Cancer

Dr Maria VICENT
RESEARCH CENTRE PRÍNCIPE FELIPE, Valencia, Spain

12:30

Lunch

Session Chair

Prof. Didier BETBEDER
UNIVERSITY LILLE 2, Lille, France

14:00

Homogeneous Conjugated Antibody with Single Point Mutation Using Bacterial Transglutaminase

Dr Florence LHOSPICE
INNATE PHARMA, Marseille, France

Session Chair

Prof. Janos SAPI
SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France

14:45

PK/PD Challenges for Antibody Drug Conjugates Development

Dr Antoine DESLANDES
SANOFI R&D, Paris, France

15:30

Coffee Break

Session Chair

Dr Nathalie MIGNET
CNRS UMR8151, PRESIDENT SFNANO, Paris, France

16:00

Chemical and Physiological Considerations in the Design of Nanosized Drug Carriers for Cancer Chemotherapy

Prof. Jean-Christophe LEROUX
ETH ZÜRICH, Zürich, Switzerland

16:45

Final Conclusions

17:00

Meeting Closure